TECLens Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Series A2

  • Latest Deal Amount
  • $10M

  • Investors
  • 4

TECLens General Information

Description

Developer of non-invasive vision correction technology designed to treat refractive errors and restore near vision. The company utilizes proprietary quantitative corneal cross-linking technology and a specialized contact lens delivery device to strengthen and reshape the cornea, enabling patients with presbyopia and other refractive conditions to improve their visual acuity through a comfortable, in-office procedure.

Contact Information

Website
www.teclens.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 9 Riverbend Drive South
  • Stamford, CT 06907
  • United States
+1 (631)
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Digital Health, HealthTech
Corporate Office
  • 9 Riverbend Drive South
  • Stamford, CT 06907
  • United States
+1 (631)

TECLens Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TECLens Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series A2) 25-Aug-2026 $10M Completed Clinical Trials - General
5. Later Stage VC 24-Jul-2026 Completed Clinical Trials - General
4. Later Stage VC (Series A) 11-Feb-2025 Completed Clinical Trials - General
3. Later Stage VC 06-Feb-2019 Completed Clinical Trials - General
2. Seed Round 02-Jun-2017 $1.16M $1.16M Completed Clinical Trials - General
1. Angel (individual) 01-Jan-2014 Completed Clinical Trials - General
To view TECLens’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

TECLens Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of non-invasive vision correction technology designed to treat refractive errors and restore near vision. The
Therapeutic Devices
Stamford, CT
6 As of 2024

Rochester, NY
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

TECLens Competitors (3)

One of TECLens’s 3 competitors is Clerio Vision, a Venture Capital-Backed company based in Rochester, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Clerio Vision Venture Capital-Backed Rochester, NY
Yolia Health Venture Capital-Backed San Diego, CA
Lumenis Private Equity-Backed Yokneam, Israel
You’re viewing 3 of 3 competitors. Get the full list »

TECLens Patents

  • 48

    Total Documents Applications and Grants

  • Total Patents Families

  • 24

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

TECLens Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4648727-A2 On-eye corneal crosslinking for control of progressive myopia and treatment of presbyopia Pending 13-Jan-2023
US-20260284425-A1 On-eye corneal crosslinking for control of progressive myopia and treatment of presbyopia Pending 13-Jan-2023
WO-2024151970-A2 On-eye corneal crosslinking for control of progressive myopia and treatment of presbyopia Inactive 13-Jan-2023
WO-2024151970-A3 On-eye corneal crosslinking for control of progressive myopia and treatment of presbyopia Inactive 13-Jan-2023
WO-2020236897-A1 Ultrasonic lens and transducer system Inactive 23-May-2019 B06B1/0644
To view TECLens’s complete patent history, request access »

TECLens Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TECLens Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Johnson & Johnson JJDC Corporate Venture Capital Minority
Rimonci Capital Venture Capital Minority
SunMed Capital Venture Capital Minority
Yonjin Venture Corporate Venture Capital Minority
To view TECLens’s complete investors history, request access »

Ready to get started?

Request a free trial

TECLens FAQs

  • When was TECLens founded?

    TECLens was founded in 2013.

  • Where is TECLens headquartered?

    TECLens is headquartered in Stamford, CT.

  • What is the size of TECLens?

    TECLens has 6 total employees.

  • What industry is TECLens in?

    TECLens’s primary industry is Therapeutic Devices.

  • Is TECLens a private or public company?

    TECLens is a Private company.

  • What is TECLens’s current revenue?

    The current revenue for TECLens is .

  • How much funding has TECLens raised over time?

    TECLens has raised $30.2M.

  • Who are TECLens’s investors?

    Johnson & Johnson JJDC, Rimonci Capital, SunMed Capital, and Yonjin Venture have invested in TECLens.

  • Who are TECLens’s competitors?

    Clerio Vision, Yolia Health, and Lumenis are competitors of TECLens.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process